AU2005249204B2 - Inactivation of a pathogen in a sample by a treatment with formalin and UV light - Google Patents

Inactivation of a pathogen in a sample by a treatment with formalin and UV light Download PDF

Info

Publication number
AU2005249204B2
AU2005249204B2 AU2005249204A AU2005249204A AU2005249204B2 AU 2005249204 B2 AU2005249204 B2 AU 2005249204B2 AU 2005249204 A AU2005249204 A AU 2005249204A AU 2005249204 A AU2005249204 A AU 2005249204A AU 2005249204 B2 AU2005249204 B2 AU 2005249204B2
Authority
AU
Australia
Prior art keywords
sample
virus
formalin
inactivation
light
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2005249204A
Other languages
English (en)
Other versions
AU2005249204A1 (en
Inventor
Noel Barrett
Otfried Kistner
Wolfgang Mundt
Manfred Reiter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ology Bioservices Inc
Original Assignee
Nanotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanotherapeutics Inc filed Critical Nanotherapeutics Inc
Publication of AU2005249204A1 publication Critical patent/AU2005249204A1/en
Application granted granted Critical
Publication of AU2005249204B2 publication Critical patent/AU2005249204B2/en
Assigned to NANOTHERAPEUTICS, INC. reassignment NANOTHERAPEUTICS, INC. Request for Assignment Assignors: BAXTER HEALTHCARE S.A., BAXTER INTERNATIONAL INC.
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A61L2/10—Ultraviolet radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M31/00—Means for providing, directing, scattering or concentrating light
    • C12M31/02—Means for providing, directing, scattering or concentrating light located outside the reactor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • A61L2103/05—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/10—Apparatus features
    • A61L2202/11—Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Sustainable Development (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2005249204A 2004-05-27 2005-05-26 Inactivation of a pathogen in a sample by a treatment with formalin and UV light Expired AU2005249204B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57531004P 2004-05-27 2004-05-27
US60/575,310 2004-05-27
PCT/EP2005/005691 WO2005118000A1 (en) 2004-05-27 2005-05-26 Inactivation of a pathogen in a sample by a treatment with formalin and uv light

Publications (2)

Publication Number Publication Date
AU2005249204A1 AU2005249204A1 (en) 2005-12-15
AU2005249204B2 true AU2005249204B2 (en) 2010-07-15

Family

ID=34968615

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005249204A Expired AU2005249204B2 (en) 2004-05-27 2005-05-26 Inactivation of a pathogen in a sample by a treatment with formalin and UV light

Country Status (17)

Country Link
EP (1) EP1753470B1 (enExample)
JP (2) JP5502276B2 (enExample)
KR (1) KR101483337B1 (enExample)
CN (1) CN1956739B (enExample)
AU (1) AU2005249204B2 (enExample)
BR (1) BRPI0511467A (enExample)
CA (1) CA2567336C (enExample)
CR (1) CR8805A (enExample)
EA (1) EA010428B1 (enExample)
EC (1) ECSP067118A (enExample)
ES (1) ES2553457T3 (enExample)
IL (1) IL179262A (enExample)
MX (1) MXPA06013633A (enExample)
NO (1) NO20065912L (enExample)
NZ (1) NZ551857A (enExample)
WO (1) WO2005118000A1 (enExample)
ZA (1) ZA200610490B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06013633A (es) * 2004-05-27 2007-03-23 Baxter Int Inactivacion de un patogeno en una muestra a traves de un tratamiento con formalina y luz ultravioleta.
GB0706507D0 (en) * 2007-04-03 2007-05-09 Medi Immune Ltd Protective device
EP2173861B2 (en) 2007-06-15 2017-02-22 Amgen Inc. Methods of treating cell culture media for use in a bioreactor
JP6200805B2 (ja) * 2010-05-03 2017-09-20 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 新規な方法
JP5968795B2 (ja) * 2013-01-10 2016-08-10 四国化工機株式会社 紫外線殺菌装置
CN103992936B (zh) * 2014-04-22 2015-10-07 北京科兴生物制品有限公司 一种封闭式甲醛灭活病毒管道系统及其应用
WO2020023942A2 (en) 2018-07-27 2020-01-30 Terumo Bct Biotechnologies, Llc Fluid flow-through
CN111840596B (zh) * 2020-06-11 2022-03-11 南岳生物制药有限公司 核黄素光化学血浆灭活装置及其控制系统、控制方法
EP4190366A4 (en) 2020-07-27 2024-11-20 Riken INFECTION PREVENTION DEVICE AND INFECTION PREVENTION METHOD
US12447225B2 (en) 2021-06-25 2025-10-21 University Of South Florida Ultrafast-UV laser integrating cavity mediated inactivation of a pathogen
CN114229953B (zh) * 2021-12-25 2022-11-18 无锡诚源环境科技有限公司 腔体式紫外消毒器的紫外线剂量计算方法
GB2631765A (en) * 2023-07-13 2025-01-15 Univ Cranfield Viral inactivation reactor and method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB802048A (en) * 1955-08-26 1958-09-24 Parke Davis & Co Vaccine products and method for producing the same
US5247178A (en) * 1991-12-12 1993-09-21 Fusion Systems Corporation Method and apparatus for treating fluids by focusing reflected light on a thin fluid layer
US20020096648A1 (en) * 2000-11-13 2002-07-25 Klaus Kaiser Apparatus for irradiating liquids

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3926556A (en) * 1973-05-30 1975-12-16 Raymond Marcel Gut Boucher Biocidal electromagnetic synergistic process
SU1367487A1 (ru) * 1986-01-29 1995-10-27 Институт полиомиелита и вирусных энцефалитов АМН СССР Способ получения антирабической вакцины
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
MXPA06013633A (es) * 2004-05-27 2007-03-23 Baxter Int Inactivacion de un patogeno en una muestra a traves de un tratamiento con formalina y luz ultravioleta.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB802048A (en) * 1955-08-26 1958-09-24 Parke Davis & Co Vaccine products and method for producing the same
US5247178A (en) * 1991-12-12 1993-09-21 Fusion Systems Corporation Method and apparatus for treating fluids by focusing reflected light on a thin fluid layer
US20020096648A1 (en) * 2000-11-13 2002-07-25 Klaus Kaiser Apparatus for irradiating liquids

Also Published As

Publication number Publication date
CA2567336A1 (en) 2005-12-15
CN1956739A (zh) 2007-05-02
EP1753470A1 (en) 2007-02-21
IL179262A0 (en) 2007-03-08
HK1105374A1 (zh) 2008-02-15
NO20065912L (no) 2007-02-26
ECSP067118A (enExample) 2007-02-28
EP1753470B1 (en) 2015-08-19
WO2005118000A1 (en) 2005-12-15
EA200602206A1 (ru) 2007-04-27
ES2553457T3 (es) 2015-12-09
JP5675690B2 (ja) 2015-02-25
IL179262A (en) 2011-01-31
CR8805A (es) 2007-06-19
JP2012143249A (ja) 2012-08-02
AU2005249204A1 (en) 2005-12-15
ZA200610490B (en) 2008-10-29
KR101483337B1 (ko) 2015-01-15
CA2567336C (en) 2010-11-23
MXPA06013633A (es) 2007-03-23
KR20110099810A (ko) 2011-09-08
BRPI0511467A (pt) 2007-12-26
JP5502276B2 (ja) 2014-05-28
CN1956739B (zh) 2011-12-28
JP2008500303A (ja) 2008-01-10
NZ551857A (en) 2009-11-27
EA010428B1 (ru) 2008-08-29

Similar Documents

Publication Publication Date Title
JP5675690B2 (ja) ホルマリンおよびｕｖ光での処理によるサンプル中の病原体の不活化
Darnell et al. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV
AU764592B2 (en) Methods and compositions for the selective modification of nucleic acids
KR101760844B1 (ko) 바이러스성 백신의 제조 방법
ES2270501T3 (es) Procedimiento para la inactivacion de virus envueltos.
US8703467B2 (en) Inactivation of a pathogen in a sample by a treatment with formalin and UV light
JP3426237B2 (ja) 生物学的組成物の滅菌方法及びこの方法によって生成される製剤
CN105431171A (zh) 用于使用电子射线来病毒灭活的方法
Gracheva et al. Immunogenic properties of SARS-CoV-2 inactivated by ultraviolet light
Vaidya et al. Ultraviolet-C irradiation for inactivation of viruses in foetal bovine serum
US6165711A (en) Process for disintegrating nucleic acids and preparing biological products of guaranteed quality
JP2021519782A (ja) 照射によって不活化されたポリオウイルス、それを含む組成物、および調製方法
US6352695B1 (en) Methods and compositions for the selective modification of nucleic acids
ES2562818T3 (es) Procedimiento de inactivación del virus de la gripe
CA2716426A1 (en) Inactivation of a pathogen in a sample by a treatment with formalin and uv light
KR20070030852A (ko) 포르말린 및 ｕｖ광으로의 처리에 의한 샘플 중 병원균의불활성화
HK1105374B (en) A method for inactivating a virus contained in a sample
US20250177534A1 (en) Thermostable uv inactivated vaccines and other biopharmaceuticals
Mayerhofer et al. UV irradiation for the manufacturing of viral vaccines: state-of-the-art and perspectives in modern vaccine processing
Gawish et al. In vitro effects of different concentrations of aqueous ozone on cells infected with herpes virus
Sofer Part 4, culture media, biotechnology products, and vaccines

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: NANOTHERAPEUTICS, INC.

Free format text: FORMER OWNER(S): BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE S.A.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired